EverGuard Gray Pourable Sealer Part A

SECTION 2: Hazards identification

GHS Classification NFPA and HMIS RATINGS: NFPA Hazard HMIS Hazard Rating Health 2 Health 2 Flammable 1 Flammable 1 Reactive 1 Reactive 1 Special Hazards - Personal Protection X

2.1 Classification of the substance or mixture

Eye Irritant - Category 1 Skin Irritant - Cateogry2A Acute Toxicity - Category 4 Mutagenicity - Category 2 Carcinogen - Category 1A

Signal word

Danger

Hazard statements

Causes skin irritation Causes serious eye damage Suspecting of causing genetic defects Suspecting of causing cancer Harmful if inhaled ADDITIONAL HAZARD IDENTIFICATION INFORMATION:

Principle Routes of Exposure

Inhalation, Skin contact SIGNS & SYMPTONS OF EXPOSURE EYES: Can cause eye irritation. Symptoms include stinging, tearing, redness and swelling of eyes. SKIN: Can cause skin irritation. Symptoms may include redness and burning of skin, and other skin damage. Additional symptoms of skin contact may include: allergic skin reaction (delayed skin rash which may be followed by blistering, scaling and other skin effects). This material is unlikely to pass into the body through the skin. INGESTION: Swallowing small amounts of this material during normal handling is not likely to cause harmful effects. Swallowing large amounts may be harmful. Swallowing this material is not likely to be harmful. INHALATION: Breathing of vapor or mist is possible. Breathing small amounts of this material during normal handling is not likely to cause harmful effects. Breathing large amounts may be harmful. Symptoms are not expected at air concentrations below the recommended exposure limits.

Acute Health Hazards

Signs and symptoms of exposure to this material through breathing, swallowing, and/or passage of the material through the skin may include: stomach or intestinal upset (nausea, vomiting, and diarrhea), irritation (nose, throat, airways).

Health hazards

Preexisting disorders of the following organs (or organ systems) may be aggravated by exposure to this material: skin, lung (for example, asthma-like conditions), kidney. CARCINOGENICITY: The International Agency for Research on Cancer (IARC) and the National Toxicology Program (NTP) have determined that there is sufficient evidence in humans for the carcinogenicity of inhaled crystalline silica in the form of quartz or cristobalite. In addition, IARC has determined that there is sufficient evidence for the carcinogenicity of quartz and cristobalite in experimental animals. Among individuals with silicosis, lung cancer occurs more frequently in those who smoke.